Quantcast

Latest Actavis Stories

2015-03-03 20:22:28

DUBLIN, March 3, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has priced an offering of $21 billion aggregate principal amount of senior unsecured notes in 10 tranches

2015-03-03 12:29:51

BOSTON, March 3, 2015 /PRNewswire/ -- Columbia Laboratories, Inc.

2015-03-02 16:31:47

DUBLIN, March 2, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has closed its concurrent offerings of 14,513,889 Ordinary Shares at $288.00 per share and 5,060,000 5.500%

2015-03-02 08:34:44

- Treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Adults - DUBLIN, March 2, 2015 /PRNewswire/-- Actavis plc (NYSE: ACT) today announced that

2015-03-02 08:33:30

DUBLIN, March 2, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it is commencing an offering of senior unsecured notes in multiple tranches in a registered public offering

2015-02-24 16:29:10

DUBLIN, Feb. 24, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S.

2015-02-20 08:26:53

DUBLIN, Feb. 20, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has received final approval from the U.S.

2015-02-18 08:30:44

- Unites Global Brand Portfolio Under Allergan Name - DUBLIN, Feb.

2015-02-18 08:30:25

- 9 mid- to late-stage compounds in development - DUBLIN, Feb.